Liming Wang

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation

Yutao Guo, Deirdre A. Lane, Limin Wang et al. · Journal of the American College of Cardiology · 2020 · 343 citations

Heart Failure, Device Therapy, Remote Patient Monitoring +16

Adjuvant Radiotherapy in Centrally Located Hepatocellular Carcinomas after Hepatectomy with Narrow Margin (<1 cm): A Prospective Randomized Study

Weibo Yu, Weihu Wang, Weiqi Rong et al. · Journal of the American College of Surgeons · 2013 · 81 citations

Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC

Bo Chen, Jianxiong Wu, Shuhui Cheng et al. · Hepatology · 2021 · 80 citations · Full text

Anlotinib in the treatment of advanced hepatocellular carcinoma: an open-label phase II study (ALTER-0802 study)

Yongkun Sun, Aiping Zhou, Wen Zhang et al. · Hepatology International · 2021 · 55 citations · Full text